{"url_path":"/sec/bfnh/8-k/2026-07-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 FINANCIAL STATMENTS AND EXHIBITS**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1310488/0001091818-26-000087-index.html","accession_number":"0001091818-26-000087","cik":"0001310488","ticker":"BFNH","issuer_name":"BIOFORCE NANOSCIENCES HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1310488/0001091818-26-000087-index.html","primary_entity_key":"0001310488","primary_entity_name":"BIOFORCE NANOSCIENCES HOLDINGS, INC."},"word_count":83,"has_tables":true,"body_markdown":"**ITEM\n9.01. FINANCIAL STATMENTS AND EXHIBITS**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit No.**\n \n**Description**\n\n \n \n \n\n[10.1](ex101.htm)\n \nRyder Scott Company Agreement\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the\nregistrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: July 01, 2026\nBIOFORCE NANOSCIENCES HOLDINGS, INC.\n\n \n \n \n\n \nBy:\n/s/ Richard Kaiser\n\n \n \nRichard Kaiser –Interim Chief Executive Officer, Chief Financial Officer and Director\n\n \n\n -3-"}